Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge.

Organisations Organisation Sphere Fluidics Ltd.
  Group Sphere Fluidics (Group)
  Organisation 2 Zyme Communications Ltd.
Products Product Cyto-Mine® Studio Software Suite
  Product 2 Cyto-Mine® Single Cell Analysis System
  Index term 2 Sphere Fluidics–Zyme Communications: public relations, 201711 service existent by Zyme
Persons Person Marchmont, Robert (Rob) (Sphere Fluidics 201903 VP Sales + Marketing before Protein Forest + GE Healthcare)
  Person 2 Ricketts, Michelle (Zyme Communications 201708– Account Manager before Axol Bioscience)

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System. The software works alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows.

Sphere Fluidics’ Cyto-Mine is an automated platform which integrates single cell screening, sorting, isolation and clone verification. Its Cyto-Mine Studio Software Suite has updated features and user interfaces for the Cyto-Mine Instrument Control Software and the off-line Cyto-Mine Data Analysis Software. It has an application programming interface (API) that enables easy communication with many industry-standard robotic platforms and links to corporate databases for easy data transfer, and includes features such as single cell dispensing to individual wells of 96- and 384-well microtiter plates and software data outputs from single cell imaging analysis.

Dr Rob Marchmont, Director of Sales and Marketing, Sphere Fluidics, said: “Developed with feedback from Sphere Fluidics’ customers, the new software has user-friendly and intuitive navigation, is secure and has programming features to allow scientists to easily monitor and run industry-standard workflows to find new rare antibody-producing cells and high-expressing cells from CHO cell lines or transfection pools. We are now updating our installed systems in Asia, Europe and the US with favorable customer feedback.”

Dr Marian Rehak, Director of R&D, Sphere Fluidics, said: “The new software is robust and brings updated features to the Cyto-Mine platform, providing high-throughput single cell analysis and monoclonality assurance for antibody discovery and cell line development. Cyto-Mine can process small numbers (e.g. a hundred thousand) of cells for monoclonality assurance through to 40 million cells for high-throughput antibody discovery. Inclusion of single cell imaging at various check points and data outputs is particularly powerful for monoclonality assurance.”

For more information about Sphere Fluidics and Cyto-Mine, please visit:


Notes to Editors

Cyto-Mine® Studio Software Suite
Dr Rob Marchmont
Dr Marian Rehak
For high-resolution images please contact Zyme Communications.

For further information please contact:

Sphere Fluidics
Dr Frank Craig, CEO
Tel: +44 (0)1223 804201

Zyme Communications
Dr Michelle Ricketts
Tel: +44 (0)778 9053 885

About Sphere Fluidics

Sphere Fluidics develops and manufactures single cell analysis and monoclonality assurance systems for biotherapeutic discovery and development.

Sphere Fluidics’ Cyto-Mine® System integrates selective screening of tens of millions of single cells, sorting, isolation and clone verification into a single automated platform to streamline workflows, reduce costs, improve throughput and enable high-value clones to be captured in a single run. Cyto-Mine® is underpinned by the Company’s patented picodroplet technology.

Sphere Fluidics is located in Babraham, Cambridgeshire (UK) and Monmouth Junction, New Jersey (USA). The Company has also internationalized its business via a global network of distributors.

Record changed: 2018-09-20


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Sphere Fluidics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top